|
Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On …
MarketWatch (press release) Before the ban, two to three million asthma sufferers in the United States relied on Primatene® Mist, because they did not have health insurance or the means to pay for a doctor's visit to get a prescription, or simply because they preferred Primatene … |
View full post on asthma – Google News